Table 1 Socio demographic and personal characteristics of the studied groups (n = 360)
Characteristics | Cases (n = 180) | Controls (n = 180) | Test | p value |
|---|---|---|---|---|
c dAge (years) | ||||
Mean ± SD | 35.05 ± 8.79 | 34.56 ± 9.06 | a0.526 | 0.600 |
c dSex no (%) | ||||
Female | 141 (78.3%) | 140 (77.8%) | b0.016 | 0.899 |
Male | 39 (21.7%) | 40 (22.2%) | ||
Smoking, no (%) | ||||
No | 150 (83.3%) | 156 (86.7%) | b0.784 | 0.376 |
Yes | 30 (16.7%) | 24 (13.3%) | ||
Infected with COVID, no (%) | ||||
No | 180 (100%) | 180 (100%) | - | - |
Yes | 0.0 (0%) | 0.0 (0%) | ||
COVID information source, no (%) | ||||
TV/radio | 39 (21.7%) | 41(22.8%) | b5.926 | 0.205 |
Internet | 42 (23.3%) | 44 (24.4%) | ||
Social media | 88 (48.9%) | 85 (47.2%) | ||
My physician | 9 (5%) | 3 (1.7%) | ||
Friends and family | 2 (1.1%) | 7 (3.9%) | ||
Rheumatological disease, no (%) | ||||
RA | 72 (40%) | - | - | - |
SLE | 67 (37.2%) | |||
Rhupus | 4 (2.2%) | |||
AS | 9 (5%) | |||
Behcet | 12 (6.7%) | |||
Sjogren | 2 (1.1%) | |||
Vasculitis | 1 (0.6%) | |||
Fibromyalgia | 5 (2.8%) | |||
Polymyalgia | 1 (0.6%) | |||
APA | 1 (0.6%) | |||
Sarcoidosis | 1 (0.6%) | |||
IBD | 1 (0.6%) | |||
Scleroderma | 1 (0.6%) | |||
DM | 1 (0.6%) | |||
PSA | 1 (0.6%) | |||
Mixed | 1 (0.6%) | |||
Lung affection, no (%) | ||||
No | 141 (78.3%) | - | - | - |
Yes | 39 (21.7%) | |||